Literature DB >> 15061492

Temporal trends in circulating Bordetella pertussis strains in Australia.

M Poynten1, P B McIntyre, F R Mooi, K J Heuvelman, G L Gilbert.   

Abstract

Australia experienced a resurgence of pertussis in the 1990s despite improved vaccine coverage. Although much of the increase was attributable to increased detection of cases in older persons with waning immunity by serology, vaccine changes or alterations in circulating Bordetella pertussis strains may also have contributed. We determined the frequency of variants of B. pertussis pertactin (prn), and pertussis toxin subunit 1 (ptxS1) genes, restriction fragment length polymorphism (RFLP) types and fimbrial serotypes prevalent in Australia prior to, and during the 1990s. Ampoules of the whole-cell vaccine in use prior to 1999 and 84 B. pertussis isolates stored between 1967 and 1998 by laboratories around Australia were analysed. One pertactin allele, Prn3, not detected before 1985, was found in 24 out of 57 (42%) isolates between 1989 and 1998 (P<0.0001). PtxS1A was found in all isolates. IS1002 type 29, found in 17 out of 31 (55%) isolates tested, was the predominant RFLP type. The only difference in fimbrial serotype distribution between the time-periods was an increase in serotype 3 (P=0.054). The whole-cell vaccine contained only the alleles prn1 and ptxS1A. Antigenic shift in B. pertussis may have contributed to the re-emergence of pertussis in Australia. Monitoring these trends will be important as acellular vaccines are introduced and changes are made to pertussis vaccine schedules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15061492      PMCID: PMC2870093          DOI: 10.1017/s095026880300164x

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  12 in total

Review 1.  The pertussis enigma: reconciling epidemiology, immunology and evolution.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Proc Biol Sci       Date:  2016-01-13       Impact factor: 5.349

2.  Antigenic divergence of Bordetella pertussis isolates in Taiwan.

Authors:  Shu-Man Yao; Yu-Chi Lin; Chen-Ying Chou; Ying-Yan Chen; Miao-Ju Hsiao; Hour-Young Chen; Jer-Jea Yan; Hsun-Pi Su; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

3.  Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years.

Authors:  Annika Elomaa; Abdolreza Advani; Declan Donnelly; Mia Antila; Jussi Mertsola; Hans Hallander; Qiushui He
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses.

Authors:  Neil K Fennelly; Federico Sisti; Sarah C Higgins; Pádraig J Ross; Han van der Heide; Frits R Mooi; Aoife Boyd; Kingston H G Mills
Journal:  Infect Immun       Date:  2008-01-14       Impact factor: 3.441

5.  Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type.

Authors:  David J Litt; Shona E Neal; Norman K Fry
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

6.  Bordetella pertussis clones identified by multilocus variable-number tandem-repeat analysis.

Authors:  Jacob Kurniawan; Ram P Maharjan; Wai Fong Chan; Peter R Reeves; Vitali Sintchenko; Gwendolyn L Gilbert; Frits R Mooi; Ruiting Lan
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

7.  Studies on Prn variation in the mouse model and comparison with epidemiological data.

Authors:  Marjolein van Gent; Inge H M van Loo; Kees J Heuvelman; Albert J de Neeling; Peter Teunis; Frits R Mooi
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

8.  Bordetella pertussis, Finland and France.

Authors:  Valérie Caro; Annika Elomaa; Delphine Brun; Jussi Mertsola; Qiushui He; Nicole Guiso
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

9.  Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003.

Authors:  Shane Byrne; Andrew T Slack
Journal:  BMC Infect Dis       Date:  2006-03-16       Impact factor: 3.090

10.  Comparison of culture and real-time PCR for detection of Bordetella pertussis isolated from patients in Iran.

Authors:  Vajiheh Sadat Nikbin; Fereshteh Shahcheraghi; Masoumeh Nakhost Lotfi; Seyyed Mohsen Zahraei; Masoumeh Parzadeh
Journal:  Iran J Microbiol       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.